Latest Filings

Issuer Activity

Insider Overview :: Theratechnologies Inc. (T:TH) [?]
Business Focus: Pharmaceuticals Share on StockTwits
Log in or sign up for a free account to add this stock to your watch list.

Holdings trends & enhanced charts available in PDF report. Click here for details »
Latest 10 SEDI filings (by transaction date) for TH within the last 6 months [?]
Amended Filing
As of 11:59pm ET February 28th, 2015
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
No SEDI filings within the past 6 months or filings data currently unavailable.
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for TH within the last 6 months [?]
Amended Filing
As of 11:59pm ET February 28th, 2015
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
No SEDI filings within the past 6 months or filings data currently unavailable.
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Sign up for an account or login above to see the past 6 months of SEDI filings sorted by insider.
No Markers (TSX Insider Summaries) for TH on February 27, 2015 [?]
To view marker data for the past week, sign up for an account or log in above.
To view more history, sign up for an account at inkresearch.com
Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEDAR
Key People
Dawn Svoronos
Chairman of the Board
Luc Tanguay
President, Chief Executive Officer, Director
Marie-Noel Colussi
Vice President - Finance
Jocelyn Lafond
Vice President - Legal Affairs, Corporate Secretary
Christian Marsolais
Vice President - Scientific Affairs and Alliances
Pierre Perazzelli
Vice President - Pharmaceutical Development
Krishna Peri
Vice President - Research
   
Company Contact
Address: 2015 Peel St 5th Floor
MONTREAL QC H3A 1T8
Tel: 1-514-3367800
Website: www.theratech.com
IR: See website
Business Overview
Theratechnologies Inc. is a Canada-based pharmaceutical company, which addresses unmet medical needs in metabolic disorders. The Company's product EGRIFTA(tesamorelin for injection), approved by the United States Food and Drug Administration helps to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. EGRIFTA (tesamorelin for injection) was also approved by Health Canada for the treatment of excess visceral adipose tissue (VAT) in treatment-experienced adult HIV-infected patients. EGRIFTA  is an injectable prescription medicine  contains a growth hormone-releasing factor (GRF).
Financial Overview
For the nine months ended 31 August 2014, Theratechnologies Inc revenues decreased 35% to C$4.1M. Net loss increased from C$1.5M to C$6.9M. Revenues reflect Royalties and licence fees decrease of 77% to C$624K, Sale of goods decrease of 70% to C$675K. Higher net loss reflects Restructuring costs decrease from C$3.1M (income) to C$0K, Selling and market development increase from C$190K to C$1.4M (expense).
Employees: 18 as of Nov 30, 2013
Reporting Currency: Canadian Dollars
Enterprise value: $45.30M as of Aug 31, 2014
Annual revenue (TTM): $5.32M as of Aug 31, 2014
EBITDA (TTM): -$13.09M as of Aug 31, 2014
Net annual income (TTM): -$9.52M as of Aug 31, 2014
Free cash flow (TTM): -$7.03M as of Aug 31, 2014
Net Debt Last Fiscal Year: $13.23M as of Aug 31, 2014
Shares outstanding: 61,010,603 as of Aug 31, 2014
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization
Competitors with Recent Insider Filings
Concordia Healthcare (T:CXR)
Cipher Pharmaceuticals (T:CPH)
Valeant Pharmaceuticals (T:VRX)
 
Theratechnologies Inc. Insider Report Only $20.00